Tests conducted on Benylin Paediatric unveiled a concerning presence of diethylene glycol, a compound associated with fatalities among infants in various countries.
The Pharmacy and Poisons Board (PPB) of
"Laboratory analysis conducted on the product showed that it contains an unacceptable high level of Diethylene glycol and was found to cause acute oral toxicity in laboratory animals," said NAFDAC' on its website.
The recalled syrup is commonly employed in the treatment of cough, congestion-related symptoms, high fever, and other allergic reactions in children aged two to 12.
Presently, the PPB is sampling significant quantities of Benylin Paediatric 100mls syrup within its authority to ascertain the levels of diethylene glycol and ethylene glycol.
"If you have a bottle from Batch No 329304, manufactured in
Copyright 2024 Business Day Africa. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com)., source